BioLife Solutions, Inc. (BLFS)
37.07
+0.69
(+1.90%)
USD |
NASDAQ |
Aug 31, 16:00
37.07
0.00 (0.00%)
Pre-Market: 20:00
BioLife Solutions Cash from Operations (Annual) : 20.12M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 20.12M |
| December 31, 2024 | 8.431M |
| December 31, 2023 | -12.50M |
| December 31, 2022 | -8.488M |
| December 31, 2021 | -4.593M |
| December 31, 2020 | 6.645M |
| December 31, 2019 | 1.213M |
| December 31, 2018 | 2.348M |
| December 31, 2017 | 0.605M |
| December 31, 2016 | -4.327M |
| December 31, 2015 | -4.974M |
| December 31, 2014 | -3.162M |
| December 31, 2013 | 0.146M |
| December 31, 2012 | 0.8549M |
| December 31, 2011 | -0.9899M |
| December 31, 2010 | -1.252M |
| Date | Value |
|---|---|
| December 31, 2009 | -2.414M |
| December 31, 2008 | -2.113M |
| December 31, 2007 | -2.709M |
| December 31, 2006 | -0.7122M |
| December 31, 2005 | -0.5763M |
| December 31, 2004 | 0.5151M |
| December 31, 2003 | -0.8542M |
| December 31, 2002 | -2.677M |
| December 31, 2001 | -2.643M |
| December 31, 2000 | -2.899M |
| December 31, 1999 | -0.2663M |
| December 31, 1998 | 0.0291M |
| December 31, 1997 | -1.495M |
| December 31, 1996 | -1.353M |
| June 30, 1995 | -1.542M |
| June 30, 1994 | -2.641M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Repligen Corp. | 117.42M |
| Agilent Technologies, Inc. | 1.559B |
| Danaher Corp. | 6.416B |
| Thermo Fisher Scientific, Inc. | 7.818B |
| West Pharmaceutical Services, Inc. | 754.80M |